Andrew Day

Andrew Day is an experienced professional in healthcare communications and public affairs, currently serving as the Owner of Link Medical since January 2012 and as Client Lead & Consultant at The Difference Collective since October 2019. Andrew has held various roles, including Consultant in Science Data Communications at AstraZeneca and Associate Director & Client Lead at BCW Global from October 2021 to May 2023. Previously, Andrew served as the Interim Head of Global Oncology Communications at Merck KGaA and as the Board Director, Head of European Communications & Public Affairs at Eisai EMEA, where responsibilities included brand and corporate communications as well as patient advocacy. Early career experience includes managing a healthcare PR agency and specializing in pharmaceutical events and communications. Andrew holds a B.Sc. in Life Sciences from the University of London, a Diploma in Marketing from the Chartered Institute of Marketing, and expertise in strategic business planning and leadership from Cranfield School of Management.